PFM
ROIV icon

Privium Fund Management’s Roivant Sciences ROIV Stock Holding History

Privium Fund Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-126,923
Closed -$1.92M – 63
2025
Q3 		$1.92M Hold
126,923
– – 0.35% 31
2025
Q2 		$1.39M Hold
126,923
– – 0.3% 26
2025
Q1 		$1.28M Sell
126,923
-88,583
-41% -$958K 0.33% 29
2024
Q4 		$2.55M Sell
215,506
-268,994
-56% -$3.18M 0.58% 26
2024
Q3 		$5.59M Hold
484,500
– – 1.39% 20
2024
Q2 		$5.12M Sell
484,500
-83,295
-15% -$913K 1.3% 22
2024
Q1 		$5.98M Buy
567,795
+290,000
+104% +$3.13M 1.6% 20
2023
Q4 		$3.15M Buy
+277,795
New +$2.71M 0.88% 28

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Privium Fund Management's ROIV Position: Q4 2025 in Review

Privium Fund Management sold out of Roivant Sciences (ROIV) in Q4 2025, closing a stake of 126,923 shares — an estimated $1.92M sold.

Privium Fund Management first reported a position in ROIV in Q4 2023 and held it in 8 quarters. The position peaked at $5.98M in Q1 2024. 399 funds tracked by Wall St. Rank hold ROIV as of Q4 2025.

  • Privium Fund Management reported no remaining Roivant Sciences position as of Q4 2025 after selling out during the quarter.
  • Privium Fund Management sold 126,923 Roivant Sciences shares in Q4 2025, an estimated $1.92M.
  • Privium Fund Management first reported a position in Roivant Sciences in Q4 2023 and held it in 8 quarters.
  • Privium Fund Management's Roivant Sciences position peaked at $5.98M in Q1 2024.
  • 399 funds tracked by Wall St. Rank held Roivant Sciences as of Q4 2025.

Based on Privium Fund Management's 13F filing for Q4 2025, filed 3 Feb 2026.